These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 23208944)

  • 21. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
    Benusiglio PR; Colas C; Guillerm E; Canard A; Delhomelle H; Warcoin M; Bellanger J; Eyries M; Zizi M; Netter J; Soubrier F; Parc Y; Mourregot A; Maran Gonzalez A; Cusin V; Denis JA; Coupier I; Svrcek M; Coulet F
    Gastric Cancer; 2019 Jul; 22(4):899-903. PubMed ID: 30515673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic predisposition to gastric cancer.
    Petrovchich I; Ford JM
    Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
    Ghaffari SR; Rafati M; Sabokbar T; Dastan J
    Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
    Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
    J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
    Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
    Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
    van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
    Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
    Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
    Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
    Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
    Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.
    van der Post RS; Gullo I; Oliveira C; Tang LH; Grabsch HI; O'Donovan M; Fitzgerald RC; van Krieken H; Carneiro F
    Adv Exp Med Biol; 2016; 908():371-91. PubMed ID: 27573781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing by cancer site: stomach.
    Chun N; Ford JM
    Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.
    Schuetz JM; Leach S; Kaurah P; Jeyes J; Butterfield Y; Huntsman D; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2272-4. PubMed ID: 23071139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of familial gastric cancer in Tuscany, a region in Italy.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Suriano G; Vindigni C; Berardi A; Garosi L; De Stefano A; Leoncini L; Seruca R; Pinto E
    Oncology; 2007; 72(3-4):243-7. PubMed ID: 18185018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds].
    Jiang Y; Wan YL; Wang ZJ; Zhao B; Zhu J; Huang YT
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):914-7. PubMed ID: 15363252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.